Centessa Pharmaceuticals Statistics
Total Valuation
CNTA has a market cap or net worth of $6.13 billion. The enterprise value is $5.95 billion.
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026, before market open.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CNTA has 154.66 million shares outstanding. The number of shares has increased by 18.56% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 154.66M |
| Shares Change (YoY) | +18.56% |
| Shares Change (QoQ) | +5.83% |
| Owned by Insiders (%) | 0.64% |
| Owned by Institutions (%) | 58.54% |
| Float | 97.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 408.41 |
| Forward PS | n/a |
| PB Ratio | 11.22 |
| P/TBV Ratio | 11.63 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 396.66 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.57, with a Debt / Equity ratio of 0.22.
| Current Ratio | 8.57 |
| Quick Ratio | 8.27 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -18.12 |
Financial Efficiency
Return on equity (ROE) is -42.55% and return on invested capital (ROIC) is -22.29%.
| Return on Equity (ROE) | -42.55% |
| Return on Assets (ROA) | -20.53% |
| Return on Invested Capital (ROIC) | -22.29% |
| Return on Capital Employed (ROCE) | -32.22% |
| Weighted Average Cost of Capital (WACC) | 11.11% |
| Revenue Per Employee | $127,119 |
| Profits Per Employee | -$1.67M |
| Employee Count | 118 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CNTA has paid $1.82 million in taxes.
| Income Tax | 1.82M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +231.74% in the last 52 weeks. The beta is 1.26, so CNTA's price volatility has been higher than the market average.
| Beta (5Y) | 1.26 |
| 52-Week Price Change | +231.74% |
| 50-Day Moving Average | 29.23 |
| 200-Day Moving Average | 23.64 |
| Relative Strength Index (RSI) | 75.82 |
| Average Volume (20 Days) | 5,082,376 |
Short Selling Information
The latest short interest is 6.61 million, so 5.19% of the outstanding shares have been sold short.
| Short Interest | 6.61M |
| Short Previous Month | 6.62M |
| Short % of Shares Out | 5.19% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.53 |
Income Statement
In the last 12 months, CNTA had revenue of $15.00 million and -$197.53 million in losses. Loss per share was -$1.46.
| Revenue | 15.00M |
| Gross Profit | 15.00M |
| Operating Income | -207.69M |
| Pretax Income | -195.71M |
| Net Income | -197.53M |
| EBITDA | -207.37M |
| EBIT | -207.69M |
| Loss Per Share | -$1.46 |
Full Income StatementBalance Sheet
The company has $294.58 million in cash and $118.38 million in debt, with a net cash position of $176.20 million or $1.14 per share.
| Cash & Cash Equivalents | 294.58M |
| Total Debt | 118.38M |
| Net Cash | 176.20M |
| Net Cash Per Share | $1.14 |
| Equity (Book Value) | 526.86M |
| Book Value Per Share | 3.53 |
| Working Capital | 324.94M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$193.82 million and capital expenditures -$371,000, giving a free cash flow of -$194.19 million.
| Operating Cash Flow | -193.82M |
| Capital Expenditures | -371,000 |
| Depreciation & Amortization | 321,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -194.19M |
| FCF Per Share | -$1.26 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -1,384.61% |
| Pretax Margin | -1,304.75% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CNTA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.56% |
| Shareholder Yield | -18.56% |
| Earnings Yield | -3.22% |
| FCF Yield | -3.17% |
Analyst Forecast
The average price target for CNTA is $42.00, which is 6.03% higher than the current price. The consensus rating is "Buy".
| Price Target | $42.00 |
| Price Target Difference | 6.03% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 126.09% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CNTA has an Altman Z-Score of 6.37 and a Piotroski F-Score of 1.
| Altman Z-Score | 6.37 |
| Piotroski F-Score | 1 |
